VIMSELTINIB for Soft tissue neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 64 adverse event reports in the FDA FAERS database where VIMSELTINIB was used for Soft tissue neoplasm.
Most Reported Side Effects for VIMSELTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 57 | 33.5% | 0 | 0 |
| Pruritus | 23 | 13.5% | 0 | 0 |
| Swelling face | 23 | 13.5% | 0 | 0 |
| Peripheral swelling | 22 | 12.9% | 0 | 0 |
| Nausea | 20 | 11.8% | 0 | 0 |
| Headache | 17 | 10.0% | 0 | 1 |
| Periorbital swelling | 17 | 10.0% | 0 | 0 |
| Eye swelling | 16 | 9.4% | 0 | 0 |
| Rash | 15 | 8.8% | 0 | 0 |
| Arthralgia | 13 | 7.7% | 0 | 0 |
| Product dose omission issue | 12 | 7.1% | 0 | 1 |
| Blood creatine phosphokinase increased | 11 | 6.5% | 0 | 0 |
| Pain | 11 | 6.5% | 0 | 0 |
| Periorbital oedema | 9 | 5.3% | 0 | 0 |
| Product use issue | 9 | 5.3% | 0 | 0 |
Other Indications for VIMSELTINIB
Giant cell tumour of tendon sheath (86)
Connective tissue neoplasm (67)
Product used for unknown indication (10)
Synovitis (9)
Other Drugs Used for Soft tissue neoplasm
PEXIDARTINIB (223)
PAZOPANIB (85)
NIROGACESTAT (40)
IMATINIB (24)
NIVOLUMAB (20)
CABOZANTINIB S-MALATE (17)
SORAFENIB (14)
SUNITINIB MALATE (14)
CABOZANTINIB (12)
IFOSFAMIDE (11)